Ligand Reports Third Quarter 2018 Financial Results
Go back to Ligand Reports Third Quarter 2018 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 288.75 -6.95 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $295.70 | 52 Week High | $139.79 | |||
| Open | $295.01 | 52 Week Low | $82.07 | |||
| Day High | $299.34 | P/E | 671.51 | |||
| Day Low | $288.60 | EPS | $0.43 | |||
| Volume | 284,529 | |||||
| Vernalis Plc Sponsored ADR (AMEX: VNLPY) | Delayed: 0.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.38 | 52 Week High | $2.43 | |||
| Open | $0.23 | 52 Week Low | $1.09 | |||
| Day High | $0.38 | P/E | N/A | |||
| Day Low | $0.38 | EPS | $0.00 | |||
| Volume | 8,366 | |||||
